Now showing items 1-4 of 4

    • ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib 

      Vivona, Douglas; Lima, Luciene Terezina; Rodrigues, Alice Cristina; Bueno, Carolina Tosin; Steinhorst Alcantara, Greyce Kelly; Ribeiro Barros, Luiza Saldanha; De Moraes Hungria, Vania Tiestsche; Chiattone, Carlos Sergio; Chauffaille, Maria de Lourdes Lopes Ferrari [UNIFESP]; Guerra-Shinohara, Elvira Maria (Spandidos Publ Ltd, 2014-04-01)
      Despite the high efficacy of imatinib mesylate (IM) treatment for chronic myeloid leukemia (CML) patients, some individuals develop resistance due to impaired bioavailability. It has been previously demonstrated that the ...

    • Anxiolytic Effect of Citrus aurantium L. on Patients with Chronic Myeloid Leukemia 

      Fernandes Pimenta, Flavia Cristina; Alves, Mateus Feitosa; Fernandes Pimenta, Martina Bragante; Linhares Melo, Silvia Adelaide; Figueiredo de Almeida, Anna Alice; Leite, Jose Roberto [UNIFESP]; Clebia de Morais Pordeus, Liana; Formiga Melo Diniz, Margareth de Fatima; de Almeida, Reinaldo Nobrega (Wiley, 2016)
      The bone marrow aspiration procedure is used in hematological diseases and consists of a painful, invasive procedure causing anxiety-associated symptoms. The present study assessed the effect of Citrus aurantium L. essential ...

    • Chronic myeloid leukemia following kidney transplantation 

      Pelloso, LAF; Campos, MGV de; Nascimento, M.; Silva, MRR; Pestana, JOM; Chauffaille, MDLF (Elsevier B.V., 2005-03-01)
      Immunosuppressed renal recipients are at an increased risk of developing cancer. Leukemias are less frequent than other hematopoietic tumours and development of CML after immunosuppression is rare. We describe a 37-year-old ...

    • Megakaryocytic blast crisis as a first presentation of chronic myeloid leukemia 

      Pelloso, Luis Arthur Flores [UNIFESP]; Baiocchi, Otavio Carvalho Guimarães [UNIFESP]; Chauffaille, Maria de Lourdes Lopes Ferrari [UNIFESP]; Yamamoto, Mihoko [UNIFESP]; Hungria, VTM; Bordin, Jose Orlando [UNIFESP] (Blackwell Munksgaard, 2002-07-01)
      Acute megakaryocytic leukemia (AmegL) corresponds to 5.0-10.0% of all acute myeloid leukemias (AML). Blast crisis as the first presentation of chronic myeloid leukemia (CML) accounts for 10.0% of all cases. Objective: We ...